Advertisement

 

 

Electroacupuncture for insomnia disorder: study protocol for a randomized controlled trial.

Electroacupuncture for insomnia disorder: study protocol for a randomized controlled trial.
Author Information (click to view)

Kim SP, Kim JH, Kim BK, Kim HJ, Jung IC, Cho JH, Kim JE, Kim MK, Kwon OJ, Kim AR, Park HJ, Seo BN,


Kim SP, Kim JH, Kim BK, Kim HJ, Jung IC, Cho JH, Kim JE, Kim MK, Kwon OJ, Kim AR, Park HJ, Seo BN, (click to view)

Kim SP, Kim JH, Kim BK, Kim HJ, Jung IC, Cho JH, Kim JE, Kim MK, Kwon OJ, Kim AR, Park HJ, Seo BN,

Advertisement

Trials 2017 04 1318(1) 177 doi 10.1186/s13063-017-1922-7
Abstract
BACKGROUND
Insomnia is a common sleep disorder that affects many adults either transiently or chronically. The societal cost of insomnia is on the rise, while long-term use of current drug treatments can involve adverse effects. Recently, electroacupuncture (EA) has been used to treat various conditions including insomnia. The objective of this study is to provide scientific evidence for the effect and safety of using EA to treat insomnia.

METHODS/DESIGN
In this multicentre, assessor-blind, three-arm, parallel-design, randomised controlled trial, 150 participants will be assigned to the EA group, the sham EA (SEA) group, or the usual care group. The EA and SEA groups will receive the specific treatments 2-3 times a week for 4 weeks, for a total of 10 sessions, whereas the usual care group will not receive EA and will continue with usual care during the same time period. The primary outcome measure will be changes in the Insomnia Severity Index 5 weeks after randomisation. The secondary outcomes will include the Pittsburgh Sleep Quality Index, the Hospital Anxiety and Depression Scale, a sleep diary, the EuroQoL-5 dimension questionnaire, the levels of melatonin and cortisol, and the Patient Global Impression of Change. Safety will be assessed at each visit.

DISCUSSION
The results of this multicentre randomised controlled trial will contribute to provide rigorous clinical evidence for the effects and safety of EA for insomnia disorder.

TRIAL REGISTRATION
Korean Clinical Trial Registry, CRIS, KCT0001685 . Registered on 2 November 2015 (retrospectively registered). Date of enrolment of the first participant to the trial 13 October 2015.

Submit a Comment

Your email address will not be published. Required fields are marked *

eighteen − fourteen =

[ HIDE/SHOW ]